| DB00114 | Pyridoxal Phosphate | For nutritional supplementation and for treating dietary shortage or imbalance. |
| DB00115 | Cyanocobalamin | For treatment of pernicious anemia (due to lack of or inhibition of intrinsic factor) and for prevention and treatment of vitamin B 12 deficiency. |
| DB00121 | Biotin | For nutritional supplementation, also for treating dietary shortage or imbalance. |
| DB00126 | Vitamin C | Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent. |
| DB00132 | Alpha-Linolenic Acid | For nutritional supplementation and for treating dietary shortage or imbalance. |
| DB00136 | Calcitriol | Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. |
| DB00140 | Riboflavin | For the treatment of ariboflavinosis (vitamin B2 deficiency). |
| DB00146 | Calcidiol | Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. |
| DB00147 | Pyridoxal | Pyridoxal is one of the natural forms available of vitamin B6, therefore, it is used for nutritional supplementation and for treating dietary shortage or imbalances. |
| DB00152 | Thiamine | For the treatment of thiamine and niacin deficiency states, Korsakov's alcoholic psychosis, Wernicke-Korsakov syndrome, delirium, and peripheral neuritis. |
| DB00153 | Ergocalciferol | For use in the management of hypocalcemia and its clinical manifestations in patients with hypoparathyroidism, as well as for the treatment of familial hypophosphatemia (vitamin D resistant rickets). This drug has also been used in the treatment of nutritional rickets or osteomalacia, vitamin D dependent rickets, rickets or osteomalacia secondary to long-term high dose anticonvulsant therapy, early renal osteodystrophy, osteoporosis (in conjunction with calcium), and hypophosphatemia associated with Fanconi syndrome (with treatment of acidosis). |
| DB00158 | Folic Acid | For treatment of folic acid deficiency, megaloblastic anemia and in anemias of nutritional supplements, pregnancy, infancy, or childhood. |
| DB00159 | Icosapent | EPA can be used for lowering elevated triglycerides in those who are hyperglyceridemic. In addition, EPA may play a therapeutic role in patients with cystic fibrosis by reducing disease severity and may play a similar role in type 2 diabetics in slowing the progression of diabetic nephropathy. |
| DB00162 | Vitamin A | For the treatment of vitamin A deficiency. |
| DB00163 | Vitamin E | Vitamin E, known for its antioxidant activities, is protective against cardiovascular disease and some forms of cancer and has also demonstrated immune-enhancing effects. It may be of limited benefit in some with asthma and rheumatoid arthritis. It may be helpful in some neurological diseases including Alzheimer's, some eye disorders including cataracts, and diabetes and premenstrual syndrome. It may also help protect skin from ultraviolet irradiation although claims that it reverses skin aging, enhances male fertility and exercise performance are poorly supported. It may help relieve some muscle cramps. |
| DB00165 | Pyridoxine | For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy. |
| DB00166 | Lipoic Acid | For nutritional supplementation, also for treating dietary shortage or imbalance. |
| DB00168 | Aspartame | Used as a diet supplement and sugar substitute. |
| DB00169 | Cholecalciferol | For the treatment of vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. |
| DB00170 | Menadione | The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification. |
| DB00200 | Hydroxocobalamin | For treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also for the treatment of known or suspected cyanide poisoning. |
| DB00627 | Niacin | For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy. |
| DB00650 | Leucovorin | For the treatment of osteosarcoma (after high dose methotrexate therapy). Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer. |
| DB00742 | Mannitol | Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances. |
| DB00974 | Edetic Acid | For the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults. |
| DB01022 | Phylloquinone | For the treatment of haemorrhagic conditions in infants, antidote for coumarin anticoagulants in hypoprothrombinaemia. |
| DB01070 | Dihydrotachysterol | Used for the prevention and treatment of rickets or osteomalacia, and to manage hypocalcemia associated with hypoparathyroidism or pseudohypoparathyroidism. Also used for the treatment of vitamin D dependent rickets, rickets or osteomalacia secondary to long-term high dose anticonvulsant therapy, early renal osteodystrophy, osteoporosis (in conjunction with calcium), and hypophosphatemia associated with Fanconi syndrome (with treatment of acidosis). |
| DB01592 | Iron | Used in preventing and treating iron-deficiency anemia. |
| DB01593 | Zinc | Not Available |
| DB01638 | Sorbitol | Used as a non-stimulant laxative via an oral suspension or enema. |
| DB01783 | Pantothenic acid | Studied for the treatment of many uses such as treatment of testicular torsion, diabetic ulceration, wound healing, acne, obesity, diabetic peripheral polyneuropathy. It has also been investigated for its hypolipidemic effects and as cholesterol lowering agent. |
| DB02701 | Nicotinamide | Not Available |
| DB02772 | Sucrose | Not Available |
| DB03323 | Maltose | Not Available |
| DB03793 | Benzoic Acid | Not Available |
| DB04173 | Fructose | Not Available |
| DB04465 | Lactose | Not Available |
| DB05382 | Iodine | Investigated for use/treatment in breast disorders (unspecified) and pain (acute or chronic). |
| DB06410 | Doxercalciferol | Doxercalciferol is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 chronic kidney disease. |
| DB06755 | Beta carotene | Not Available |
| DB06757 | Manganese | Indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. |
| DB08830 | Dehydroascorbic Acid | There is no approved indication for dehydroascorbic acid, but it has potential therapeutic use in patients with certain viruses and ischemic stroke. |
| DB08842 | Acetylcarnitine | Acetylcarnitine is not approved for any indication in the United states and Canada, but it is approved and indicated in Italy for cerebrovascular disorders, mental function disorders, peripheral nerve disorders, diabetic neuropathy, and nutritional supplementation; Portugal for mental function disorders; Argentina for cerebral vasculopathy, nutritional supplementation, and peripheral neuropathy; Chile for dementia; Philippines for cerebrovascular disorders and mental function disorders; Australia for nutritional supplementation; and India for nutritional supplementation to increase sperm count. Acetylcarnitine also has several potential therapeutic indications for which it is still being investigated: in Norway, acetylcarnitine is in a phase IV trial for prophylactic treatment of migraines; in Italy acetylcarnitine is in a phase II trial for use in patients with type 2 Diabetes Mellitus, a phase III trial for alleviating fatigue in patients with chronic hepatitis C, and for use in patients with Minimal Hepatic Encephalopathy; in the United States acetylcarnitine is in a phase II trial for the neurodegenerative disorder Progressive Supranuclear Palsy, a phase II and III trial for reducing peripheral neuropathy in cancer patients as an adjunct to chemotherapy, a phase I and II trial for treating patients in septic shock, a phase II trial for bipolar depression, a phase II trial to reduce oxidative stress in patients with Sickle Cell disease, a phase I and II trial for chronic fatigue syndrome, and a study for preventing nerve damage in HIV patients; in China acetylcarnitine is in a phase III trial for reducing peripheral neuropathy in cancer patients as an adjunct to chemotherapy; in the United Kingdom acetylcarnitine is being investigated for preventing nerve damage in HIV patients; and in Israel acetylcarnitine is being studied for the treatment of male infertility.
|
| DB08887 | Icosapent ethyl | Icosapent ethyl is used as adjunct therapy to reduce triglyceride (TG) levels in adults with severe (>500 mg/dL) hypertriglyceridemia. |
| DB08966 | Fursultiamine | Not Available |
| DB09112 | Sodium Nitrite | For sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning that is judged to be life-threatening [FDA Label]. |
| DB09130 | Copper | For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801]. |
| DB09220 | Nicorandil | Indicated for the prevention and treatment of chronic stable angina pectoris and reduction in the risk of acute coronary syndromes. |
| DB09270 | Ubidecarenone | Not Available |
| DB09341 | Glucose | Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used in metabolic disorders such as hypoglycemia. |
| DB09344 | Invert sugar | Not Available |
| DB09422 | Soybean oil | Indicated for parenteral nutrition as a source of calories and essential fatty acids when oral or enteral nutrition is not possible, insufficient, or contraindicated. |
| DB09567 | Olive oil | For use in adults as a source of calories and fatty acids in total parenteral nutrition [FDA Label]. Sometimes used as an additive in cosmetic products. |
| DB10516 | Casein | Not Available |
| DB11086 | Cocoa butter | Not Available |
| DB11093 | Calcium Citrate | For use as an over the counter calcium supplement. |
| DB11094 | Vitamin D | Not Available |
| DB11127 | Selenious acid | Not Available |
| DB11133 | Omega-3 fatty acids | Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia. |
| DB11134 | Cupric oxide | Not Available |
| DB11135 | Selenium | For the supplementation of total parenteral nutrition to prevent hyposelenemia [FDA Label]. |
| DB11136 | Chromium | Not Available |
| DB11137 | Molybdenum | Not Available |
| DB11172 | Sesame oil | Not Available |
| DB11195 | Xylitol | Not Available |
| DB11203 | Boron | Not Available |
| DB11251 | Tocopherol | Not Available |
| DB11253 | Xanthan gum | Not Available |
| DB11292 | Docosahexaenoate | Not Available |
| DB11321 | Cod liver oil | Not Available |
| DB11596 | Levoleucovorin | Levoleucovorin is indicated for use as rescue therapy following high-dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists. Levoleucovorin, as the product Fusilev (FDA, dosed at one-half the usual dose of racemic d,l-leucovorin), has an additional indication for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer (although they should not be mixed in the same infusion as a precipitate may form). |
| DB11673 | Pyridoxamine | Not Available |
| DB12418 | Saccharin | Not Available |
| DB12647 | Tocotrienol | Not Available |
| DB12942 | Lactitol | Not Available |
| DB12982 | Silicon | Not Available |
| DB13105 | Resolvin E1 | Not Available |
| DB13178 | Inositol | Not Available |